# Effect of Antacids on the Pharmacokinetics of Raltegravir

> **NCT00944307** · PHASE1 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 17 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** raltegravir
- **DRUG:** antacid

## Key facts

- **NCT ID:** NCT00944307
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944307, "Effect of Antacids on the Pharmacokinetics of Raltegravir". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00944307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
